In last trading session, Mainz Biomed N.V. (NASDAQ:MYNZ) saw 1.37 million shares changing hands with its beta currently measuring 0.11. Company’s recent per share price level of $0.30 trading at -$0.02 or -6.29% at ring of the bell on the day assigns it a market valuation of $6.52M. That closing price of MYNZ’s stock is at a discount of -1030.0% from its 52-week high price of $3.39 and is indicating a premium of 36.67% from its 52-week low price of $0.19. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.98 million shares which gives us an average trading volume of 1.89 million if we extend that period to 3-months.
Mainz Biomed N.V. (NASDAQ:MYNZ) trade information
Upright in the red during last session for losing -6.29%, in the last five days MYNZ remained trading in the red while hitting it’s week-highest on Friday, 10/11/24 when the stock touched $0.30 price level, adding 13.04% to its value on the day. Mainz Biomed N.V.’s shares saw a change of -74.31% in year-to-date performance and have moved -7.97% in past 5-day. Mainz Biomed N.V. (NASDAQ:MYNZ) showed a performance of 17.28% in past 30-days. Number of shares sold short was 2.27 million shares which calculate 0.99 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mainz Biomed N.V. (MYNZ) estimates and forecasts
Statistics highlight that Mainz Biomed N.V. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -67.04% of value to its shares in past 6 months, showing an annual growth rate of 45.68% while that of industry is 17.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 34.10% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 220k for the same. And 2 analysts are in estimates of company making revenue of 300k in the next quarter.
Mainz Biomed N.V. (NASDAQ:MYNZ)’s Major holders
NORTHERN TRUST CORP is the top institutional holder at MYNZ for having 29934.0 shares of worth $12004.0. And as of 2024-06-30, it was holding 0.1414 of the company’s outstanding shares.
The second largest institutional holder is VONTOBEL HOLDING LTD., which was holding about 25000.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.1181 of outstanding shares, having a total worth of $10025.0.
